Team owner Mukesh Kochhar hails 'outstanding’ ladies as he pays tribute to his tried and tested squad of players
The drug, which will be marketed under the brand name Covifor, will likely be priced at Rs5,000-6,000 rupees for a 100 milligram dose, Hetero said.
India's Cipla said its generic version of remdesivir will be called Cipremi.
The Drug Controller General of India (DCGI) was not immediately available for comment.
Gilead Sciences Inc signed non-exclusive licensing pacts last month with five generic drugmakers based in India and Pakistan to expand the supply of its Covid-19 treatment.
The pacts allow Jubilant Life Sciences Ltd, Cipla, Hetero Labs, Mylan NV and Ferozsons Laboratories Ltd to make and sell the drug in 127 countries.
Indian drugmaker Zydus Cadila said last week it signed a non-exclusive licensing pact with Gilead Sciences to manufacture and market remdesivir.
Team owner Mukesh Kochhar hails 'outstanding’ ladies as he pays tribute to his tried and tested squad of players
Authorities said the decision has been taken keeping the safety of the public in mind
Inflation objective remains distant, US Federal Reserve says
Divided into at least three separate areas, the park will be a first-of-its-kind protected area in the emirate
Lidia Stepanivna: She walked without food or water, and fell several times but her 'character' kept her going
Dubai Police said that the emirate is expected to witness weather fluctuations during the coming hours
UN estimates the amount of debris in the Gaza Strip at 37 million tonnes in mid-April, or 300 kilogrammes per square metre
Ports, Customs, and Free Zone Corporation also advised to refrain from sailing unless absolutely necessary